Templewater has announced its acquisition of OncoCare Medical and Novena Heart Centre, leading oncology and cardiology private clinic groups in Singapore.

Information on the Target

Templewater is set to acquire OncoCare Medical ("OncoCare") and Novena Heart Centre ("NHC"), both of which are leading private clinic groups specializing in oncology and cardiology in Singapore. OncoCare, established in 2007, operates a network of seven clinics strategically located within renowned hospitals, providing services from a team of 13 specialized oncologists. The clinic group caters to a diverse patient base that includes both local residents and international clients.

NHC, also founded in 2007, is recognized as one of the largest multi-disciplinary cardiology groups in Singapore, with three advanced clinics situated in prime areas. The team consists of five cardiologists who cover various subspecialties, offering comprehensive inpatient and outpatient cardiology services.

Industry Overview in Singapore

Singapore's healthcare sector is renowned for its advanced and efficient medical services, showcasing a blend of public and private healthcare facilities. It has consistently been ranked as one of the top he

View Source

Similar Deals

Tamarind Health TalkMED

2025

Buyout Hospitals, Clinics & Primary Care Services Singapore
EFOR Group Process Engineering Specialists

2025

Buyout Biopharmaceuticals Singapore
Templewater TalkMED Group Limited

2025

Buyout Hospitals, Clinics & Primary Care Services Singapore
LYFE Capital FSP Holdings Pte. Ltd.

2023

Buyout Medical Devices & Implants Singapore
TBS Energi Utama Asia Medical Enviro Services

2023

Buyout Healthcare Facilities & Services (NEC) Singapore
Efor Project Delivery Partners (PDP)

2023

Buyout Biotechnology & Medical Research (NEC) Singapore

Templewater

invested in

OncoCare Medical and Novena Heart Centre

in 2023

in a Buyout deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert